Cargando…
Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression
BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for b...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769547/ https://www.ncbi.nlm.nih.gov/pubmed/33391742 http://dx.doi.org/10.1093/ckj/sfaa002 |
_version_ | 1783629347690643456 |
---|---|
author | Koeze, Jacqueline van der Horst, Iwan C C Keus, Frederik Wiersema, Renske Dieperink, Wim Kootstra-Ros, Jenny E Zijlstra, Jan G van Meurs, Matijs |
author_facet | Koeze, Jacqueline van der Horst, Iwan C C Keus, Frederik Wiersema, Renske Dieperink, Wim Kootstra-Ros, Jenny E Zijlstra, Jan G van Meurs, Matijs |
author_sort | Koeze, Jacqueline |
collection | PubMed |
description | BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for biomarkers for earlier AKI detection. Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48 h of ICU admission in an unselected, heterogeneous ICU patient population. METHODS: We conducted a prospective observational study in an academic tertiary referral ICU population. We recorded AKI progression in all ICU patients during the first 48 h of ICU admission in a 6-week period. Plasma NGAL was measured at admission but levels were not reported to the attending clinicians. As possible predictors of AKI progression, pre-existing AKI risk factors were recorded. We examined the association of clinical parameters and plasma NGAL levels at ICU admission with the incidence and progression of AKI within the first 48 h of the ICU stay. RESULTS: A total of 361 patients were included. Patients without AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 115 ng/mL [interquartile range (IQR) 81–201]. Patients with AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 156 ng/mL (IQR 97–267). To predict AKI progression, a multivariant model with age, sex, diabetes mellitus, body mass index, admission type, Acute Physiology and Chronic Health Evaluation score and SCr at admission had an area under the receiver operating characteristics (ROC) curve of 0.765. Adding NGAL to this model showed a small increase in the area under the ROC curve to 0.783 (95% confidence interval 0.714–0.853). CONCLUSIONS: NGAL levels at admission were higher in patients with progression of AKI during the first 48 h of ICU admission, but adding NGAL levels at admission to a model predicting this AKI progression showed no significant additive value. |
format | Online Article Text |
id | pubmed-7769547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77695472020-12-31 Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression Koeze, Jacqueline van der Horst, Iwan C C Keus, Frederik Wiersema, Renske Dieperink, Wim Kootstra-Ros, Jenny E Zijlstra, Jan G van Meurs, Matijs Clin Kidney J Original Articles BACKGROUND: Acute kidney injury (AKI) is a common complication in patients during intensive care unit (ICU) admission. AKI is defined as an increase in serum creatinine (SCr) and/or a reduction in urine output. SCr is a marker of renal function with several limitations, which led to the search for biomarkers for earlier AKI detection. Our aim was to study the predictive value of plasma neutrophil gelatinase-associated lipocalin (NGAL) at admission as a biomarker for AKI progression during the first 48 h of ICU admission in an unselected, heterogeneous ICU patient population. METHODS: We conducted a prospective observational study in an academic tertiary referral ICU population. We recorded AKI progression in all ICU patients during the first 48 h of ICU admission in a 6-week period. Plasma NGAL was measured at admission but levels were not reported to the attending clinicians. As possible predictors of AKI progression, pre-existing AKI risk factors were recorded. We examined the association of clinical parameters and plasma NGAL levels at ICU admission with the incidence and progression of AKI within the first 48 h of the ICU stay. RESULTS: A total of 361 patients were included. Patients without AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 115 ng/mL [interquartile range (IQR) 81–201]. Patients with AKI progression during the first 48 h of ICU admission had median NGAL levels at admission of 156 ng/mL (IQR 97–267). To predict AKI progression, a multivariant model with age, sex, diabetes mellitus, body mass index, admission type, Acute Physiology and Chronic Health Evaluation score and SCr at admission had an area under the receiver operating characteristics (ROC) curve of 0.765. Adding NGAL to this model showed a small increase in the area under the ROC curve to 0.783 (95% confidence interval 0.714–0.853). CONCLUSIONS: NGAL levels at admission were higher in patients with progression of AKI during the first 48 h of ICU admission, but adding NGAL levels at admission to a model predicting this AKI progression showed no significant additive value. Oxford University Press 2020-02-17 /pmc/articles/PMC7769547/ /pubmed/33391742 http://dx.doi.org/10.1093/ckj/sfaa002 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Koeze, Jacqueline van der Horst, Iwan C C Keus, Frederik Wiersema, Renske Dieperink, Wim Kootstra-Ros, Jenny E Zijlstra, Jan G van Meurs, Matijs Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title | Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title_full | Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title_fullStr | Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title_full_unstemmed | Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title_short | Plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
title_sort | plasma neutrophil gelatinase-associated lipocalin at intensive care unit admission as a predictor of acute kidney injury progression |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769547/ https://www.ncbi.nlm.nih.gov/pubmed/33391742 http://dx.doi.org/10.1093/ckj/sfaa002 |
work_keys_str_mv | AT koezejacqueline plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT vanderhorstiwancc plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT keusfrederik plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT wiersemarenske plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT dieperinkwim plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT kootstrarosjennye plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT zijlstrajang plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression AT vanmeursmatijs plasmaneutrophilgelatinaseassociatedlipocalinatintensivecareunitadmissionasapredictorofacutekidneyinjuryprogression |